The annual BHF conference is taking place in Cape Town from 14 -17 May 2023
The annual BHF conference is taking place in Cape Town from 14 -17 May 2023. Networking, collaboration and learning about emerging healthcare issues, innovation and industry action, and discussions regarding what’s next.
Recent Posts
EU Approves Imfinzi Gastric Cancer Treatment as Perioperative Immunotherapy
Imfinzi gastric cancer treatment has received European Commission approval for adults with resectable, early-stage and locally advanced (Stages II, III, IVA) gastric and gastroesophageal junction (GEJ) cancers. AstraZeneca’s Imfinzi (durvalumab), a PD-L1 inhibitor, combined with FLOT chemotherapy...
FDA Biosimilar Approval Reforms: Accelerating Access and Reducing Drug Costs
The US Food and Drug Administration (FDA) has introduced biosimilar approval reforms to accelerate development and adoption, tackling biologic drug costs that exceeded 50% of total US drug spending in 2024. These biosimilar approval reforms address burdensome criteria stifling uptake, despite 82 ...
FDA Warning Letter Novo Nordisk Reveals Serious Compliance Failures in Adverse Drug Reporting
The U.S. Food and Drug Administration (FDA) issued the FDA Warning Letter Novo Nordisk dated March 5, 2026, to Novo Nordisk Inc. (NNI)...